Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.

I’m joined by Rick Winningham, Chairman and CEO of Theravance Biopharma.

Rick has led Theravance since its spin-out from Innoviva in 2014, after serving as CEO of Innoviva and holding senior leadership roles at Bristol Myers Squibb. He’s also been a driving force in industry advocacy, chairing the California Life Sciences Association and serving on the boards of Jazz Pharmaceuticals, Rivus, and BIO.

At Theravance, he’s steering strategy, innovation, and execution in a challenging market — drawing on decades of experience to navigate cycles, build strong teams, and keep advancing transformative medicines.

Enjoy and stay tuned.